Ledger.Open graph →
SEC Form D · filed May 19, 2014

ALIOS BIOPHARMA INC

Offering
$41.0M
Sold
$41.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Peter Hirth · South San Francisco, CADirectorLawrence Blatt · South San Francisco, CAExec · DirectorLeonid Beigelman · South San Francisco, CAExecJack Nielsen · South San Francisco, CADirectorCampbell Murray · South San Francisco, CADirectorJens Eckstein · Boston, MADirectorSimon Ridgway · Vancouver, British Columbia, CanadaExec · DirectorMario Szotlender · Vancouver, British Columbia, CanadaExecInvestment Manager Bny Mellon, N.A · Pittsburgh, PADirectorCharles A. Warden · Menlo Park, CADirectorFrederick W. Telling · Seattle, WADirectorJohn Donovan · Sunnyvale, CAExecJens Eckstein · Montreal, Quebec, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗